Envestnet Asset Management Inc Mustang Bio, Inc. Transaction History

Envestnet Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.46 - $0.76 $30,788 - $50,868	-66,932 Reduced 76.99%	20,000 $9,000
Q2 2022 Aug 03, 2022	BUY	$0.58 - $1.13 $15,349 - $29,905	26,465 Added 43.77%	86,932 $51,000
Q1 2022 May 04, 2022	BUY	$0.73 - $1.81 $13,253 - $32,862	18,156 Added 42.91%	60,467 $61,000
Q4 2021 Feb 04, 2022	BUY	$1.66 - $2.64 $40,890 - $65,031	24,633 Added 139.34%	42,311 $70,000
Q3 2021 Oct 07, 2021	BUY	$2.58 - $3.36 $4,956 - $6,454	1,921 Added 12.19%	17,678 $48,000

Q2 2021 Aug 04, 2021	BUY	$2.7 - $3.81 $9,733 - $13,735	3,605 Added 29.67%	15,757 $52,000
Q1 2021 May 04, 2021	BUY	$3.02 - $5.16 $36,699 - $62,704	12,152 New	12,152 $40,000
Q1 2020 Apr 23, 2020	SELL	$1.91 - $4.52 $19,100 - $45,199	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.71 - $7.58 $57,100 - $75,800	10,000 New	10,000 $60,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.